Table 2 Administration of adjuvant CT and ET in patients within the indicated area for 70-GS use who received the 70-GS, i.e., in whom controversy exists regarding the administration of adjuvant CT based on conventional prognostic factors

From: Using a gene expression signature when controversy exists regarding the indication for adjuvant systemic treatment reduces the proportion of patients receiving adjuvant chemotherapy: a nationwide study